Repligen Corporation is a company in the U.S. stock market and it is a holding in 115 U.S.-traded ETFs. RGEN has around 5.8M shares in the U.S. ETF market. The largest ETF holder of RGEN is the iShares Core S&P Mid-Cap ETF (IJH), with approximately 1.43M shares. Investors may also find of interest that the ETF with the largest allocation to RGEN stock is Franklin Genomic Advancements ETF (HELX), with a portfolio weight of 5.82%. On average, U.S. ETFs allocate 0.38% of RGEN to their portfolios.
Additionally, RGEN is a favorite stock for Vanilla and Multi-factor ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with RGEN as a holding is the SPDR S&P 1500 Value Tilt ETF (VLU), with a return of 20.34%.